scholarly journals FP410INITIATION OF MENOPAUSE HORMONE THERAPY AND SUBSEQUENT KIDNEY FUNCTION DECLINE IN THE STOCKHOLM CREATININE MEASUREMENTS (SCREAM) PROJECT

2019 ◽  
Vol 34 (Supplement_1) ◽  
Author(s):  
Ilaria Mariani ◽  
Marco Trevisan ◽  
Nele Brusselaers ◽  
Rino Bellocco ◽  
Arvid Sjölander ◽  
...  
Author(s):  
Jae Young Kim ◽  
Young Su Joo ◽  
Jong Hyun Jhee ◽  
Seung Hyeok Han ◽  
Tae-Hyun Yoo ◽  
...  

2021 ◽  
pp. 1-21
Author(s):  
Hui Zhang ◽  
Yi Li ◽  
Meng Hao ◽  
Xiaoyan Jiang ◽  
Jiucun Wang ◽  
...  

Abstract Background: Few studies have been conducted to investigate the association of kidney function decline with the trajectories of homocysteine (Hcy) over time, using repeated measurements. We aimed to investigate the association of kidney function with changes in plasma Hcy levels over time. Methods: Data were collected from the Rugao Longevity and Ageing Study. In detail, plasma Hcy and creatinine levels were measured in both waves (waves 2, 3 and 4) during the 3.5-year follow-up (N = 1135). Wave 2 was regarded as the baseline survey. The estimated glomerular filtration rate (eGFR) was calculated based on creatinine. Subjects were categorized into four groups according to quartiles of eGFR at baseline. Linear mixed-effect models were used to investigate the association of eGFR with subsequent plasma Hcy levels. Results: The mean eGFR at baseline was 90.84 (11.42) mL/min/1.73 m2. The mean plasma Hcy level was 14.09 (6.82) at baseline and increased to 16.28 (8.27) and 17.36 (10.39) μmol/L during follow-ups. In the crude model, the interaction between time and eGFR at baseline was significant (β = −0.02, 95% CI: −0.02 to −0.01, p = 0.002). After adjusting for confounding factors, a significant relationship remained (β = −0.02, 95% CI: −0.02 to −0.01, p = 0.003), suggesting that kidney function decline at baseline was associated with a faster increase in Hcy levels. Conclusion: Kidney function decline is associated with a more pronounced increase in plasma Hcy levels. Further studies with longer follow-up periods and larger sample sizes are needed to validate our findings.


2009 ◽  
Vol 30 (3) ◽  
pp. 171-178 ◽  
Author(s):  
Michael G. Shlipak ◽  
Ronit Katz ◽  
Bryan Kestenbaum ◽  
Linda F. Fried ◽  
Anne B. Newman ◽  
...  

2021 ◽  
Vol 41 (5) ◽  
pp. 427-433
Author(s):  
Bernarda Viteri ◽  
Mohamed Elsingergy ◽  
Jennifer Roem ◽  
Derek Ng ◽  
Bradley Warady ◽  
...  

2014 ◽  
Vol 10 (1) ◽  
pp. 63-73 ◽  
Author(s):  
Vasantha Jotwani ◽  
Rebecca Scherzer ◽  
Alison Abraham ◽  
Michelle M. Estrella ◽  
Michael Bennett ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document